In this issue:
Health-related QoL with pembrolizumab
Prevalence of HPV DNA & P16 positivity in vulvar cancer
Risk factors for chemoradiation and brachytherapy in cervical cancer
Offering HPV sample kits
Obstetric outcomes after medroxyprogesterone use in endometrial cancer
Neoadjuvant chemotherapy and debulking surgery for endometrial cancer
Cemiplimab for recurrent cervical cancer
Financial toxicity and health-related QoL
Consensus statement on the management of VIN
Predictive biomarkers for ICI effectiveness in endometrial cancer
Please login below to download this issue (PDF)